Cardea Bio Revenue and Competitors
Estimated Revenue & Valuation
- Cardea Bio's estimated annual revenue is currently $1.2M per year.
- Cardea Bio's estimated revenue per employee is $77,500
- Cardea Bio's total funding is $22.9M.
Employee Data
- Cardea Bio has 16 Employees.
- Cardea Bio grew their employee count by -48% last year.
Cardea Bio's People
Name | Title | Email/Phone |
---|---|---|
1 | Controller & Director Finance | Reveal Email/Phone |
2 | Chief Scientific Officer | Reveal Email/Phone |
3 | Chief Business Officer | Reveal Email/Phone |
4 | Senior Director, Multiomics Assay Development | Reveal Email/Phone |
5 | Senior Director, Manufacturing and Supply Chain | Reveal Email/Phone |
6 | Project Manager | Production Engineer & Supervisor | Reveal Email/Phone |
7 | Production Team Member, Graphene Transfer | Reveal Email/Phone |
Cardea Bio Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $4.4M | 57 | -8% | $53M | N/A |
#2 | $21.2M | 137 | -26% | $110M | N/A |
#3 | $0.9M | 6 | 0% | N/A | N/A |
#4 | $2.3M | 15 | 15% | N/A | N/A |
#5 | $1.6M | 10 | -17% | N/A | N/A |
#6 | $0.7M | 9 | 50% | N/A | N/A |
#7 | $11.5M | 74 | -12% | N/A | N/A |
#8 | $0.4M | 275 | 10% | $236.7M | N/A |
#9 | $4M | 51 | -74% | $160M | N/A |
#10 | $2.3M | 15 | 15% | N/A | N/A |
What Is Cardea Bio?
Cardea is developing a Tech+Bio Infrastructure based on proprietary Biology-gated Transistors, or Cardean Transistors. Cardean Transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with live-streams of multi-omics signal analysis. Until now, life science data was comprised of static snapshot datasets. Cardea uses Cardean Transistors to build chipsets that can be integrated into thousands of “Powered by Cardea†products and applications with features never before seen. Together with their Innovation Partners, Cardea can link biology to computers and measure real-time biological signals - allowing for a new generation of applications Linking up to Life.Â
keywords:N/A$22.9M
Total Funding
16
Number of Employees
$1.2M
Revenue (est)
-48%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Cardea Bio News
This milestone is an important move for Cardea Bio on its mission to realizing real-world applications of their BPU (Biosignal Processing Unit)...
Cardea Bio is the world's only mass producer of a biocompatible semiconductor, the BPU (Biosignal Processing Unit). The BPU is the first and...
San Diego-based Cardea Bio, a startup that is developing molecular biology equipment which uses semiconductors to analyze samples, said on Tuesday that it has raised $6.5M more in its Series A funding. The company said the new funding was led by 3E Bioventures Capital, and also included existing ...
San Diego-based Cardea Bio, a manufacturer of graphene-based, digital biosensors being used to monitor biological systems using semiconductors, announced this morning that it has raised $7.8M in a Series A-1 financing round. The financing was led by Alexandria Venture Investments, and also inclu ...
Cardea Bio Inc., a San Diego, CA-based commercial manufacturer of the biology-enabled transistor technology made from graphene-based biosensors, raised $7.8m Series A-1 financing. The round was led by Alexandria Venture Investments, with participation from new and existing investors, including ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.4M | 16 | N/A | N/A |
#2 | $1.4M | 16 | N/A | N/A |
#3 | $1.4M | 16 | N/A | N/A |
#4 | $1.4M | 16 | 7% | N/A |
#5 | $4M | 16 | 0% | N/A |